{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:59:28Z","timestamp":1776326368709,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12288-019-01143-4","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T05:14:08Z","timestamp":1559798048000},"page":"47-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CML in Elderly: Does Age Matter?"],"prefix":"10.1007","volume":"36","author":[{"given":"Kadabur Nagendrappa","family":"Lokesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8922-2544","authenticated-orcid":false,"given":"Jitendra Kumar","family":"Pehalajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dassappa","family":"Loknatha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linu Abraham","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C. Suresh","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Rudresha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakkavalli Krishnappa","family":"Rajeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. C.","family":"Smitha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khandare Pravin","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. S.","family":"Madhumathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"1143_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0971-5851.123712","volume":"34","author":"P Mishra","year":"2013","unstructured":"Mishra P, Seth T, Mahapatra M et al (2013) Report of chronic myeloid leukemia in chronic phase from All India Institute of Medical Sciences, 1990\u20132010. Indian J Med Paediatr Oncol 34:159\u2013163","journal-title":"Indian J Med Paediatr Oncol"},{"key":"1143_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","volume":"63","author":"JE Sokal","year":"1984","unstructured":"Sokal JE, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE et al (1984) Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia. Blood 63:789\u2013799","journal-title":"Blood"},{"key":"1143_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/jnci\/90.11.850","volume":"90","author":"J Hasford","year":"1998","unstructured":"Hasford J, Pfirrmann M, Hehlmann R, Allan NC, Baccarani M, Kluin-Nelemans JC et al (1998) A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. J Natl Cancer Inst 90:850\u2013858","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"1143_CR4","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/sj.leu.2403042","volume":"17","author":"U Berger","year":"2003","unstructured":"Berger U, Engelich G, Maywald O et al (2003) Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha. Leukemia 17(9):1820\u20131826","journal-title":"Leukemia"},{"issue":"6","key":"1143_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/PPO.0b013e318237e5b7","volume":"17","author":"DW Woessner","year":"2011","unstructured":"Woessner DW, Lim CS, Deininger MW et al (2011) Development of an effective therapy for chronic myelogenous leukemia. Cancer J (Sudbury, MA.) 17(6):477\u2013486","journal-title":"Cancer J (Sudbury, MA.)"},{"key":"1143_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.25336\/P61G7S","volume":"43","author":"AM Bali","year":"2017","unstructured":"Bali AM (2017) Population ageing in India. Can Stud Popul 43:299. \nhttps:\/\/doi.org\/10.25336\/P61G7S","journal-title":"Can Stud Popul"},{"issue":"1","key":"1143_CR7","doi-asserted-by":"publisher","first-page":"e2014037","DOI":"10.4084\/mjhid.2014.037","volume":"6","author":"L Balducci","year":"2014","unstructured":"Balducci L, Dolan D (2014) Chronic myelogenous leukemia (CML) in the elderly. Mediterr J Hematol Infect Dis 6(1):e2014037","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"1143_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/cncr.11629","volume":"98","author":"J Costes","year":"2003","unstructured":"Costes J, Talpaz M, O\u2019Brien S et al (2003) Effects of age on prognosis with imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myelogenous leukemia. Cancer 98:1105\u20131113","journal-title":"Cancer"},{"key":"1143_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1182\/asheducation-2011.1.128","volume":"2011","author":"A Hochhaus","year":"2011","unstructured":"Hochhaus A (2011) Educational session: managing chronic myeloid leukemia as a chronic disease. Hematol Am Soc Hematol Educ Program 2011:128\u2013135. \nhttps:\/\/doi.org\/10.1182\/asheducation-2011.1.128","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1143_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3324\/haematol.10239","volume":"92","author":"G Rosti","year":"2007","unstructured":"Rosti G, Iacobucci I, Bassi S et al (2007) Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party. Haematologica 92:101\u2013105","journal-title":"Haematologica"},{"key":"1143_CR11","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1002\/cncr.28106","volume":"119","author":"AM Brunner","year":"2013","unstructured":"Brunner AM, Campigotto F, Sadrzadeh H et al (2013) Trends in all cause mortality among patients with chronic myeloid leukemia: a Surveillance Epidemiology and End Results Data base analysis. Cancer 119:2620\u20132629","journal-title":"Cancer"},{"key":"1143_CR12","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1200\/JCO.2011.34.7146","volume":"29","author":"M Bjorkholm","year":"2011","unstructured":"Bjorkholm M, Ohm L, Eloranta S et al (2011) Success story of targeted therapy in Chronic Myeloid leukemia: a population based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol 29:2514\u20132520","journal-title":"J Clin Oncol"},{"key":"1143_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40266-013-0088-6","volume":"30","author":"R Latagliata","year":"2013","unstructured":"Latagliata R, Ferrero D, Iurlo A et al (2013) Imatinib in very elderly patients with chronic myeloid leukemia in chronic stage: a retrospective study. Drugs Aging 30:629\u2013637","journal-title":"Drugs Aging"},{"issue":"3","key":"1143_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1179\/102453308X316004","volume":"13","author":"OM Sheehy","year":"2008","unstructured":"Sheehy OM, Irvine AE, Cuthbert RJ, Humphreys MW, McMullin MF (2008) Use of imatinib mesylate in elderly patients in Northern Ireland: evidence of comparable haematological and molecular responses to younger patients. Hematology 13(3):133\u2013136","journal-title":"Hematology"},{"issue":"6","key":"1143_CR15","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1182\/blood.V66.6.1326.1326","volume":"66","author":"H Kantarjian","year":"1985","unstructured":"Kantarjian H, Smith TL, McCredie K et al (1985) Chronic myelogenous leukemia: a multivariate analysis of the associations of patients\u2019 characteristics and therapy with survival. Blood 66(6):1366\u20131375","journal-title":"Blood"},{"issue":"1","key":"1143_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.critrevonc.2012.01.001","volume":"84","author":"M Breccia","year":"2012","unstructured":"Breccia M, Tiribelli M, Alimena G et al (2012) Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety data. Crit Rev Oncol Hematol 84(1):93\u2013100","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-019-01143-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-019-01143-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-019-01143-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:27:27Z","timestamp":1591313247000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-019-01143-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1007\/s12288-019-01143-4","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"6 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was taken from all patients prior to the clinical examination, any procedure and before starting treatment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}